Celgene Corp (CELG)

Add to Watchlists
Create an Alert
98.47 +0.07  +0.07% NASDAQ Sep 16, 13:14 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
10/25/2019 09:00 EDT Misc Celgene Corp Third Quarter Earnings Conference Call in 2019
10/25/2019 Earnings Celgene Corp Third Quarter Earnings in 2019 Release
07/30/2019 Earnings Celgene Corp Second Quarter Earnings Results in 2019
06/12/2019 Misc Celgene Corp Annual General Meeting for 2018
04/25/2019 Earnings Celgene Corp First Quarter Earnings in 2019 Release
01/31/2019 09:00 EST Misc Celgene Corp Fourth Quarter Earnings Conference Call in 2018
01/31/2019 Earnings Celgene Corp Fourth Quarter Earnings Results in 2018
10/25/2018 09:00 EDT Misc Celgene Corp Third Quarter Earnings Conference Call in 2018
10/25/2018 Earnings Celgene Corp Third Quarter Earnings Results in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.celgene.com
  • Investor Relations URL: http://ir.celgene.com/
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Oct. 25, 2019
  • Last Earnings Release: Jul. 30, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.

Top Fund Holders

Symbol Name Weighting
IBB iShares Nasdaq Biotechnology ETF 8.14%
HQH Tekla Healthcare Investors 7.84%
MNA IQ Merger Arbitrage ETF 7.65%
BCLPX BlackRock Event Driven Equity Inv C 7.19%
FIJYX Fidelity Advisor® Biotechnology Z 6.66%
XLV Health Care Select Sector SPDR® ETF 2.03%
FNKLX Fidelity® Series Value Discovery 1.80%
VHCIX Vanguard Health Care Index Admiral 1.58%
VHT Vanguard Health Care ETF 1.58%
XBI SPDR® S&P Biotech ETF 1.48%
TEDRX Franklin Mutual Global Discovery R 1.36%
FDMLX Fidelity® Series Intrinsic Opps 1.00%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("CELG","name")
  • Description: =YCI("CELG","description")
  • Sector: =YCI("CELG","sector")
  • Industry: =YCI("CELG","industry")
  • Est. Current Fiscal Year End: =YCI("CELG","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.